Digital Surgery Technologies Market Scope
While it is easy to define digital surgery in terms of the technologies involved, we recognise that it also includes advances in medical science and data working in tandem with technology. Robotics, artificial intelligence (AI), advanced imaging, connected devices, and advanced instrumentation are all technological advancements at the heart of digital surgery. The convergence of all of these technologies has the potential to be transformative. Technological advancements benefit both patients and the industry as a whole. At the same time, they have the potential to disrupt existing healthcare business models. Indeed, we are seeing examples of digital disruption, albeit on a smaller scale, in areas such as telemedicine with existing and former start-ups.
|Unit||Value (USD Million)|
|Key Companies Profiled||Johnson & Johnson (United States), Osso VR (United States), Augmedics Ltd. (United states), Brainlab AG (Germany), Medtronic plc (Ireland), Caresyntax, Inc. (United States), 3Dintegrated ApS (Denmark), DASH Analytics (United States), Novadaq Technologies, Inc. (Canada) and Fundamental VR (United Kingdom)|
The digital surgery landscape continues to evolve, with significant uncertainty about the rate of technological change and market adoption. Furthermore, both traditional and non-traditional medical players are heavily investing in this space. Companies are looking to make acquisitions to improve the capabilities of their solutions. Innovative point solutions across therapeutic areas, the patient journey, and the technology landscape will dominate the coming years. Players who are large, established, and well-capitalized. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Digital Surgery Technologies market throughout the predicted period.
Johnson & Johnson (United States), Osso VR (United States), Augmedics Ltd. (United states), Brainlab AG (Germany), Medtronic plc (Ireland), Caresyntax, Inc. (United States), 3Dintegrated ApS (Denmark), DASH Analytics (United States), Novadaq Technologies, Inc. (Canada) and Fundamental VR (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are EchoPixel, Inc. (United States), Surgical Science Sweden AB. (Sweden), VirtaMed AG (Switzerland), Mimic Technologies (United States) and Centerline Biomedical (United States).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
The study have segmented the market of Global Digital Surgery Technologies market by Type , by Application (Joint surgery, Facial trauma, Maxillomandibular reconstruction, Implantology and Restorative dentistry) and Region with country level break-up.
On the basis of geography, the market of Digital Surgery Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.
Market Leaders and their expansionary development strategiesIn February 2021, Medical technology company Medtronic has announced the acquisition of Digital Surgery, a UK-based firm with a focus on surgical artificial intelligence (AI), data, and analytics. The expectations from this acquisition are to strengthen Medtronic’s portfolio and its robotic-assisted surgery platform.
In January 2022, The Johnson & Johnson Medical Devices Companies (JJMDC) will form a strategic partnership with Microsoft to further enhance and broaden its digital surgery ecosystem. Under the partnership, Microsoft will serve as the preferred Cloud provider for JJMDC’s digital surgery solutions. The collaboration with Microsoft will also allow JJMDC to expand its digital surgery platform and Internet of Things (IoT) device connectivity. With a focus on advancing skills, enhancing workflows, and improving surgical decision-making, JJMDC will leverage the Microsoft Cloud technologies, including Azure, artificial intelligence (AI), and machine learning, as well as Dynamics 365 and Microsoft 365 to accelerate its innovations.
The FDA has cleared RAS devices for use by trained physicians in an operating room environment for laparoscopic surgical procedures in general surgery, cardiac, colorectal, gynecologic, head and neck, thoracic and urologic surgical procedures. Some common procedures that may involve RAS devices are gall-bladder removal, hysterectomy, and prostatectomy (removal of the prostate). and While robotically-assisted surgery is safe and effective for performing certain procedures when used appropriately and with proper training, the FDA has not granted marketing authorization for any robotically-assisted surgical device system for use in the United States specifically for the prevention or treatment of cancer.
Digital Surgery Technologies Market Dynamics:
|Trends Influencing Market|
- Higher Accuracy and Faster Recovery are leading to an Increasing No. of People Opting for Robotic-Assisted Orthopaedic Surgeries.
- Higher Costs Driven by Purchase of the Robotic System, Maintenance and the Disposable Instruments Required for Each Procedure, Training, Technical Support, and Insurance.
- Insufficient Evidence of the Effectiveness Is Responsible For Low Confidence in Its Adoption
- Existing Healthcare Infrastructure, Especially in Rural Areas, is Inadequate to Meet the Ever-Growing Healthcare Needs of the Population Leading to Surging Healthcare Demand.
Key Target AudienceAI&ML Companies, Pharmaceutical companies, Medical instruments Manufacturers, Hospitals and Healthcare companies, New Entrants and Investors, Legalized Cannabis Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others